Abstract
Nowadays, retinal vein occlusion (RVO) is the second most prevalent cause of vision loss associated with retinal vascular disease. Intravitreal injections are currently known as a major advancement in ophthalmology, particularly in the treatment of RVO and other retinal disorders. Particularly, the first line of therapy is usually anti-vascular endothelial growth factor (VEGF) drugs. Notably, for RVO eyes that have not responded to anti-VEGF therapy, an intravitreal dexamethasone (DEX) implant 0.7 mg (Ozurdex®, AbbVie Inc., North Chicago, IL, USA) is considered a suitable therapeutical substitute. Actually, investigations carried out in the real world and clinical trials have shown the safety and the efficacy of intravitreal DEX implants for treating this retinal disease. For this reason, choosing patients carefully may thus be essential to reduce the number of injections that clinics and hospitals have to do to manage RVO and its complications. The primary aim of this review is to summarize the pathophysiology of this retinal vascular disease, as well as the clinical and ocular imaging features that may support a switch from prior anti-VEGF treatment to intravitreal DEX implant, to provide the RVO patients with the best possible treatment to ensure maximum visual recovery.
Share and Cite
MDPI and ACS Style
Vitiello, L.; Lixi, F.; Coppola, A.; Abbinante, G.; Gagliardi, V.; Salerno, G.; De Pascale, I.; Pellegrino, A.; Giannaccare, G.
Intravitreal Dexamethasone Implant Switch after Anti-VEGF Treatment in Patients Affected by Retinal Vein Occlusion: A Review of the Literature. J. Clin. Med. 2024, 13, 5006.
https://doi.org/10.3390/jcm13175006
AMA Style
Vitiello L, Lixi F, Coppola A, Abbinante G, Gagliardi V, Salerno G, De Pascale I, Pellegrino A, Giannaccare G.
Intravitreal Dexamethasone Implant Switch after Anti-VEGF Treatment in Patients Affected by Retinal Vein Occlusion: A Review of the Literature. Journal of Clinical Medicine. 2024; 13(17):5006.
https://doi.org/10.3390/jcm13175006
Chicago/Turabian Style
Vitiello, Livio, Filippo Lixi, Alessia Coppola, Giulia Abbinante, Vincenzo Gagliardi, Giulio Salerno, Ilaria De Pascale, Alfonso Pellegrino, and Giuseppe Giannaccare.
2024. "Intravitreal Dexamethasone Implant Switch after Anti-VEGF Treatment in Patients Affected by Retinal Vein Occlusion: A Review of the Literature" Journal of Clinical Medicine 13, no. 17: 5006.
https://doi.org/10.3390/jcm13175006
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details
here.
Article Metrics
Article Access Statistics
For more information on the journal statistics, click
here.
Multiple requests from the same IP address are counted as one view.